Jim Simons Medical Devices

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
DXCM Dexcom Inc	$28.5B	$69.2 Million 0.11% of portfolio	889,874	Q4 2024 Added 7.09%
UFPT Ufp Technologies Inc	$1.5B	$68.3 Million 0.11% of portfolio	279,159	Q4 2024 Reduced 0.09%
EW Edwards Lifesciences Corp	$43.6B	$48.3 Million 0.08% of portfolio	652,493	Q4 2024 Reduced 46.59%
MDT Medtronic PLC	$120B	$46 Million 0.07% of portfolio	575,341	Q4 2024 Reduced 56.17%
PODD Insulet Corp	$18.6B	$41.5 Million 0.07% of portfolio	158,993	Q4 2024 Added 45.74%
INMD In Mode Ltd.	$1.55B	$37.9 Million 0.06% of portfolio	2,266,618	Q4 2024 Added 2.26%
IRMD Iradimed Corp	$658M	$28.2 Million 0.04% of portfolio	513,012	Q4 2024 Reduced 4.91%
INSP Inspire Medical Systems, Inc.	$4.75B	$25.3 Million 0.04% of portfolio	136,700	Q4 2024 Added 36.02%
PRCT Procept Bio Robotics Corp	$2.59B	$22.4 Million 0.04% of portfolio	278,466	Q4 2024 New
RXST Rx Sight, Inc.	$687M	$12.4 Million 0.02% of portfolio	361,500	Q4 2024 Added 102.86%
TNDM Tandem Diabetes Care Inc	$1.3B	$11.4 Million 0.02% of portfolio	315,727	Q4 2024 Added 50.04%
NARI Inari Medical, Inc.	$4.27B	$9.93 Million 0.02% of portfolio	194,599	Q4 2024 Reduced 16.44%
ANIK Anika Therapeutics, Inc.	$225M	$8.7 Million 0.01% of portfolio	528,517	Q4 2024 Reduced 7.96%
TCMD Tactile Systems Technology Inc	$272M	$7.73 Million 0.01% of portfolio	451,100	Q4 2024 Added 44.03%
GKOS Glaukos Corp	$4.87B	$7.44 Million 0.01% of portfolio	49,600	Q4 2024 Added 30.55%
ARAY Accuray Inc	$170M	$5.9 Million 0.01% of portfolio	2,979,998	Q4 2024 Added 6.79%
LIVN Liva Nova PLC	$2.11B	$5.21 Million 0.01% of portfolio	112,594	Q4 2024 Added 9.21%
ZIMV Zim Vie Inc.	$304M	$5.01 Million 0.01% of portfolio	356,300	Q4 2024 Reduced 8.45%
FONR Fonar Corp	$90.7M	$4.75 Million 0.01% of portfolio	313,716	Q4 2024 Reduced 5.94%
INGN Inogen Inc	$168M	$4.52 Million 0.01% of portfolio	492,900	Q4 2024 Added 17.95%
BVS Bioventus Inc.	$595M	$4.08 Million 0.01% of portfolio	388,700	Q4 2024 Added 0.21%
VREX Varex Imaging Corp	$502M	$3.79 Million 0.01% of portfolio	259,700	Q4 2024 Added 9.62%
ELMD Electromed, Inc.	$210M	$3.5 Million 0.01% of portfolio	118,333	Q4 2024 Reduced 4.11%
BFLY Butterfly Network, Inc.	$457M	$3.12 Million 0.0% of portfolio	1,001,100	Q4 2024 Reduced 52.14%
BWAY Brainsway Ltd.	$164M	$3.09 Million 0.0% of portfolio	329,660	Q4 2024 Reduced 8.72%
LNSR Lensar, Inc.	$163M	$3.08 Million 0.0% of portfolio	348,891	Q4 2024 Added 13.3%
CTKB Cytek Biosciences, Inc.	$565M	$3 Million 0.0% of portfolio	462,600	Q4 2024 Added 118.62%
VMD Viemed Healthcare, Inc.	$277M	$2.99 Million 0.0% of portfolio	373,000	Q4 2024 Added 2.3%
SRTS Sensus Healthcare, Inc.	$78M	$2.95 Million 0.0% of portfolio	430,934	Q4 2024 Added 5.28%
ATEC Alphatec Holdings, Inc.	$1.04B	$2.68 Million 0.0% of portfolio	292,100	Q4 2024 Added 106.29%
PEN Penumbra Inc	$10.6B	$1.92 Million 0.0% of portfolio	8,100	Q4 2024 Reduced 91.0%
DCTH Delcath Systems, Inc.	$118M	$1.63 Million 0.0% of portfolio	138,242	Q4 2024 Reduced 55.66%
SIBN Si Bone, Inc.	$503M	$1.56 Million 0.0% of portfolio	111,400	Q4 2024 New
LUNG Pulmonx Corp	$290M	$1.5 Million 0.0% of portfolio	220,510	Q4 2024 Added 38.68%
OFIX Orthofix Medical Inc.	$333M	$1.44 Million 0.0% of portfolio	82,190	Q4 2024 Added 166.93%
SGHT Sight Sciences, Inc.	$138M	$1.43 Million 0.0% of portfolio	393,006	Q4 2024 Added 654.33%
TELA Tela Bio, Inc.	$28.2M	$1.28 Million 0.0% of portfolio	425,140	Q4 2024 Added 185.52%
MYO Myomo, Inc.	$37.7M	$1.24 Million 0.0% of portfolio	199,600	Q4 2024 Added 39.48%
MXCT Maxcyte, Inc.	$314M	$1.17 Million 0.0% of portfolio	281,200	Q4 2024 Added 47.92%
NVRO Nevro Corp	$204M	$1.12 Million 0.0% of portfolio	300,309	Q4 2024 Reduced 5.24%
NPCE Neuro Pace Inc	$299M	$965,000 0.0% of portfolio	86,300	Q4 2024 Reduced 0.8%
ICAD Icad Inc	$56.5M	$870,000 0.0% of portfolio	475,593	Q4 2024 Reduced 20.9%
TMCI Treace Medical Concepts, Inc.	$457M	$833,000 0.0% of portfolio	112,000	Q4 2024 Added 217.28%
OM Outset Medical, Inc.	$482M	$762,000 0.0% of portfolio	686,748	Q4 2024 Added 1,167.67%
SENS Senseonics Holdings, Inc.	$344M	$715,000 0.0% of portfolio	1,376,020	Q4 2024 New
QIPT Quipt Home Medical Corp.	$81.4M	$700,000 0.0% of portfolio	229,600	Q4 2024 Added 6.15%
MASS 908 Devices Inc.	$143M	$648,000 0.0% of portfolio	294,956	Q4 2024 Reduced 8.51%
IRIX Iridex Corp	$15.8M	$647,000 0.0% of portfolio	381,160	Q4 2024 Reduced 4.08%
CERS Cerus Corp	$271M	$640,000 0.0% of portfolio	415,609	Q4 2024 Reduced 25.58%
QTRX Quanterix Corp	$267M	$628,000 0.0% of portfolio	59,100	Q4 2024 Reduced 55.26%

Shares Options

Jim Simons

Jim Simons is the founder and chairman of Renaissance Technologies, a successful investment firm that uses quantitative approaches to investing. Simons is known for his expertise in mathematical modeling and has a reputation for being a skilled and successful investor. He has generated strong returns for his clients over the long term.

Track Jim Simons's portfolio

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account